From the ER to the High School Football Field, People Want the Response to Covid-19 to Be Evidence-based, not Political
By the Children’s Health Defense Team To date, the FDA has only approved a single therapeutic (Remdesivir) specifically for Covid-19—and that drug is, according to many, of questionable benefit. In situations where approved therapeutic options are lacking, health care providers typically draw on their knowledge of comparable ailments, their problem-solving skills and their prior experience using solidly vetted therapies […]
» Lire la suite